文献速递慢性肾脏病

RARRES1通过KHDRBS1/Src/p-STAT3轴促进肾小管纤维化

Retinoic Acid Receptor Responder Protein 1 Promotes Tubular Fibrosis via the KH RNA Binding Domain Containing, Signal Transduction Associated 1/Steroid Receptor Coactivator/p-Signal Transducer and Activator of Transcription 3 Axis.
PubMed 文献 · J Am Soc Nephrol · 2026-04-09

本研究探讨RARRES1在CKD肾小管间质纤维化中的作用。临床数据集显示肾小管间质RARRES1表达与eGFR下降及纤维化严重程度相关。近端小管特异性敲除Rarres1减轻小鼠肾纤维化,而过表达则加重。机制上可溶性RARRES1结合KHDRBS1,招募Src激酶并诱导STAT3 Tyr705磷酸化。抑制STAT3或Src可部分逆转纤维化表型。

要点

  • CKD患者肾小管间质RARRES1表达升高,与eGFR下降和纤维化加重相关
  • 近端小管Rarres1敲除减轻小鼠肾纤维化,过表达加重纤维化
  • 可溶性RARRES1通过KHDRBS1/Src/p-STAT3轴促进纤维化,抑制该轴可部分逆转

核心结论

  • RARRES1通过KHDRBS1/Src/p-STAT3信号轴调控肾脏纤维化,发挥重要作用。

研究设计与样本

  • 分析多个CKD患者临床数据集,评估肾小管间质RARRES1表达与eGFR及纤维化严重程度的关系。
  • 采用免疫荧光和RNAscope在人CKD样本中确认近端小管上皮细胞RARRES1上调。
  • 使用近端小管特异性Rarres1敲除小鼠和RARRES1过表达小鼠,在单侧输尿管梗阻和叶酸诱导肾病模型中评估肾纤维化。
  • 通过质谱、共免疫沉淀和截短突变体鉴定可溶性RARRES1、KHDRBS1、Src激酶和磷酸化STAT3之间的相互作用。
  • 使用STAT3或Src激酶药理学阻断评估逆转RARRES1诱导的纤维化表型。

主要发现

  • 多个数据集显示CKD患者肾小管间质RARRES1表达与eGFR下降和纤维化严重程度增加相关。
  • 免疫荧光和RNAscope证实CKD中RARRES1特异性在近端小管上皮细胞上调。
  • 近端小管特异性敲除Rarres1在两种独立CKD模型中显著减轻肾纤维化。
  • RARRES1过表达小鼠在单侧输尿管梗阻模型中较对照组肾纤维化加重。
  • 可溶性RARRES1为关键致病形式,其血浆水平与CKD患者肾功能下降相关;机制上可溶性RARRES1结合KHDRBS1,招募Src激酶,诱导STAT3 Tyr705磷酸化,上调促纤维化因子;抑制STAT3或Src激酶部分逆转RARRES1过表达诱导的纤维化表型。

临床怎么用

  • RARRES1及其下游KHDRBS1/Src/p-STAT3轴可能作为CKD肾纤维化的潜在治疗靶点。
  • 药理学抑制STAT3或Src激酶可部分逆转RARRES1过表达诱导的纤维化表型,提示转化潜力。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

KEY POINTS: Retinoic acid receptor responder protein 1 is upregulated in proximal tubular epithelial cells in CKD. Soluble retinoic acid receptor responder protein 1 drives fibrosis by binding KH RNA binding domain containing, signal transduction associated 1, recruiting steroid receptor coactivator kinase, and inducing signal transducer and activator of transcription 3 phosphorylation. BACKGROUND: Kidney fibrosis is a hallmark of CKD, yet its underlying mechanisms remain incompletely understood. Retinoic acid receptor responder protein 1 (RARRES1) is largely restricted to podocytes in healthy kidneys but was upregulated within the tubulointerstitium in CKD. However, its functional contribution to kidney fibrosis remains unclear. METHODS: To assess the link between tubulointerstitial RARRES1 expression, eGFR, and fibrosis severity in patients with CKD, we analyzed multiple clinical datasets. RARRES1 upregulation in proximal tubular epithelial cells was confirmed in human CKD samples by immunofluorescence and RNAscope assays. Kidney fibrosis was evaluated in proximal tubule-specific Rarres1 knockout mice and RARRES1-overexpressing mice after CKD induction, including unilateral ureteral obstruction and folic acid-induced nephropathy. Mechanistically, mass spectrometry and coimmunoprecipitation, combined with truncation mutants, uncovered interactions among soluble RARRES1, KH RNA binding domain containing, signal transduction associated 1 (KHDRBS1), steroid receptor coactivator (Src) kinase, and phosphorylated signal transducer and activator of transcription 3 (STAT3). Pharmacologic blockade of STAT3 or Src kinase was used to evaluate the reversal of RARRES1-induced fibrotic phenotype. RESULTS: Multiple datasets revealed that tubulointerstitial RARRES1 expression correlated with decreased eGFR and increased fibrosis severity in patients with CKD. Immunofluorescence and RNAscope confirmed RARRES1 upregulation specifically in proximal tubular epithelial cells in CKD. Proximal tubule-specific knockout of Rarres1 significantly attenuated kidney fibrosis in two independent CKD models. Conversely, RARRES1-overexpressing mice showed aggravated kidney fibrosis compared with controls in the unilateral ureteral obstruction model. Soluble RARRES1 was identified as the key pathogenic form, with its plasma levels correlating with declining kidney function in patients with CKD. Mechanistically, soluble RARRES1 bound KHDRBS1, recruited Src kinase, and induced STAT3 phosphorylation at Tyr705, leading to upregulation of profibrotic factors. Inhibition of STAT3 or Src kinase partially reversed the fibrotic phenotype induced by RARRES1 overexpression. CONCLUSIONS: Our findings demonstrated that RARRES1 played an important role in regulating kidney fibrosis through the KHDRBS1/Src/p-STAT3 signaling axis.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Ye L, Jiang Z, Wu Y, et al. Retinoic Acid Receptor Responder Protein 1 Promotes Tubular Fibrosis via the KH RNA Binding Domain Containing, Signal Transduction Associated 1/Steroid Receptor Coactivator/p-Signal Transducer and Activator of Transcription 3 Axis. J Am Soc Nephrol. 2026. PMID: 41955023. doi:10.1681/ASN.0000001081

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。